Clinical genetics in breast cancer

Area of Science:

• Oncology
• Genetics
• Medical Guidelines

Background:

• Genetic testing is becoming more accessible and clinically relevant for breast cancer.
• Keeping breast cancer providers updated on genetic testing advancements is challenging.
• Germline and genomic testing have broad applications in breast cancer care.

Purpose of the Study:

• To review current clinical guidelines for germline and genomic testing in breast cancer.
• To summarize recent literature on the role of genetic testing in breast cancer.
• To identify future research directions in breast cancer genetic testing.

Main Methods:

• Literature review of current clinical guidelines.
• Synthesis of recent research findings.
• Identification of knowledge gaps and future research needs.

Main Results:

• The review outlines established guidelines for genetic testing in breast cancer.
• Recent literature demonstrates expanding applications of germline and genomic testing.
• Key areas for future research are identified to address evolving clinical needs.

Conclusions:

• Staying current with genetic testing in breast cancer requires ongoing review of guidelines and research.
• Germline and genomic testing are integral to breast cancer screening, prevention, diagnosis, and treatment.
• Further research is needed to optimize the use of genetic testing in breast cancer management.